A Garre

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study

María Chaparro, A Verreth, Triana Lobatón et al. · The American Journal of Gastroenterology · 2018 · 171 citations

Medicine, Immunology, Pediatrics +16

Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry

María Chaparro, A Garre, Francisco Mesonero et al. · Journal of Crohn s and Colitis · 2020 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry

María Chaparro, A Garre, Marisa Iborra et al. · Journal of Crohn s and Colitis · 2021 · 81 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Differences between childhood‐ and adulthood‐onset inflammatory bowel disease: the <scp>CAROUSEL</scp> study from <scp>GETECCU</scp>

María Chaparro, A Garre, Elena Ricart et al. · Alimentary Pharmacology & Therapeutics · 2019 · 44 citations · Full text

Medicine, Immunology, Pediatrics +14

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients

María Chaparro, Manuel Barreiro‐de Acosta, Ana Echarri et al. · Digestive Diseases and Sciences · 2018 · 30 citations · Full text

Veterinary Medicine, Immunology, Pathology +16